Letter/Comment

Dec 21, 2020
AHA letter requesting the Biden Administration exercise enforcement discretion with respect to compliance with the Centers for Medicare…
May 25, 2022
AHA comments on the Internal Revenue Service’s (IRS) proposed rule amending how employer coverage affordability would be measured for family members of employees.
May 24, 2022
The AHA urges the FTC to increase scrutiny on insurer-mandated white bagging policies, as well as the impact of PBM-negotiated rebates and other business practices on the 340B drug discount pricing program and overall drug prices and drug price increases.
May 19, 2022
AHA urges CMS to take swift action to hold Medicare Advantage (MA) plans accountable for inappropriately and illegally restricting beneficiary access to medically necessary care.
May 19, 2022
The AHA urges the Department of Justice to establish a task force to conduct False Claims Act investigations into commercial health insurance companies that are found to routinely deny patients access to services and deny payments to health care providers.
May 16, 2022
The AHA letter to GE regarding the current supply disruptions and shortages of Omnipaque as a result of the temporary closure of GE Healthcare’s (GE) manufacturing facility in Shanghai, China.
May 12, 2022
Nearly 30 organizations, including the AHA, urge congressional appropriators to increase funding for the Children’s Hospitals Graduate Medical Education program to $718.8 million in fiscal year 2023.
May 10, 2022
The AHA and other national health care organizations urge Health and Human Services Secretary Xavier Becerra to maintain the public health emergency until it’s clear that the global pandemic has receded and the capabilities authorized by the PHE are no longer necessary.